BioAge Labs (BIOA) Earnings Analysis

BioAge Labs (BIOA) has no confirmed upcoming earnings date. Last quarter (2026-05-08) it beat with EPS -0.52 USD vs -0.63959 USD est (+18.7%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E -9.14.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does BIOA next report earnings?

No confirmed upcoming earnings date is currently scheduled for BIOA. This page updates as the calendar is published.

BIOA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-08-0.52 USD-0.63959 USD+18.7%Beat
2026-03-24-0.72 USD-0.83 USD+13.3%Beat
2025-11-06-0.56 USD-0.67 USD+16.4%Beat
2025-03-20-1.97 USD-0.58 USD-239.7%Miss
2024-11-07-6.7 USD-0.72 USD-830.6%Miss

Beat rate: 3/5 (60%) over reported quarters with consensus data.

BIOA valuation and analyst view

Trailing P/E-9.14
Trailing EPS-2.11697 USD
Price / book2.46
Dividend yield0.00%
Market cap0.83B
Analyst consensusBuy (2 buy / 1 hold / 0 sell)
Avg price target38 USD

Related research pages

Frequently asked questions

When is BioAge Labs (BIOA)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for BIOA. This page updates as the calendar is published.

Did BIOA beat earnings last quarter?

In its 2026-05-08 report, BIOA posted EPS of -0.52 USD versus a -0.63959 USD estimate — a beat of 18.7%.

What is BIOA's earnings track record?

Over the last 5 reported quarters with consensus data, BIOA beat estimates 3 times (60%).

What is BIOA's current P/E ratio and EPS?

BIOA trades at a trailing P/E of -9.14 on trailing EPS of -2.1169719142586123 USD.

What do analysts rate BIOA?

Analyst consensus is "Buy" across 3 ratings (0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 38 USD.